Free Trial
NASDAQ:MDCX

Medicus Pharma (MDCX) Stock Price, News & Analysis

Medicus Pharma logo
$2.45 -1.18 (-32.51%)
As of 04:00 PM Eastern

About Medicus Pharma Stock (NASDAQ:MDCX)

Key Stats

Today's Range
$2.34
$3.04
50-Day Range
$3.13
$7.78
52-Week Range
$1.80
$8.94
Volume
1.97 million shs
Average Volume
115,339 shs
Market Capitalization
$33.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$23.50
Consensus Rating
Strong Buy

Company Overview

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.

Medicus Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
37th Percentile Overall Score

MDCX MarketRank™: 

Medicus Pharma scored higher than 37% of companies evaluated by MarketBeat, and ranked 748th out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medicus Pharma has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Medicus Pharma has only been the subject of 3 research reports in the past 90 days.

  • Read more about Medicus Pharma's stock forecast and price target.
  • Short Interest

    There is no current short interest data available for MDCX.
  • Dividend Yield

    Medicus Pharma does not currently pay a dividend.

  • Dividend Growth

    Medicus Pharma does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for MDCX.
  • News Sentiment

    Medicus Pharma has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for Medicus Pharma this week, compared to 2 articles on an average week.
  • Search Interest

    11 people have searched for MDCX on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 6 people have added Medicus Pharma to their MarketBeat watchlist in the last 30 days. This is a decrease of -14% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Medicus Pharma insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $579,000.00 in company stock.

  • Read more about Medicus Pharma's insider trading history.
Receive MDCX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicus Pharma and its competitors with MarketBeat's FREE daily newsletter.

MDCX Stock News Headlines

Medicus Pharma unveils pricing of $7M public offering
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
MDCX Medicus Pharma Ltd.
See More Headlines

MDCX Stock Analysis - Frequently Asked Questions

Medicus Pharma's stock was trading at $2.43 at the beginning of the year. Since then, MDCX stock has increased by 0.8% and is now trading at $2.45.
View the best growth stocks for 2025 here
.

Medicus Pharma Ltd. (NASDAQ:MDCX) announced its earnings results on Monday, May, 12th. The company reported ($0.42) earnings per share for the quarter, missing analysts' consensus estimates of ($0.23) by $0.19.

Medicus Pharma (MDCX) raised $4 million in an initial public offering (IPO) on Thursday, November 14th 2024. The company issued 1,000,000 shares at a price of $4.13 per share. Maxim Group LLC acted as the underwriter for the IPO and Brookline Capital Markets was co-manager.

Top institutional investors of Medicus Pharma include Interchange Capital Partners LLC (12.39%), Armistice Capital LLC (9.43%) and Private Advisor Group LLC (0.42%).
View institutional ownership trends
.

Shares of MDCX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/12/2025
Today
5/30/2025
Next Earnings (Estimated)
6/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MDCX
Previous Symbol
NASDAQ:MDCX
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.50
High Stock Price Target
$27.00
Low Stock Price Target
$20.00
Potential Upside/Downside
+859.2%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$33.06 million
Optionable
N/A
Beta
N/A
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:MDCX) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners